Physician profile
Daniel P Logsdon
NPI 1437506821
$314,485.26
in general payments reported to CMS, 2019-2025
25 companies · $123K in 2025
The $123K reported for 2025 was more than what 99% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,289 · 2020: $2,179 · 2021: $2,728 · 2022: $20K · 2023: $74K · 2024: $83K · 2025: $123K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $201K · Travel and Lodging: $44K · Food and Beverage: $22K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $201,181.32 |
| Travel and Lodging | $44,308.32 |
| Food and Beverage | $21,658.37 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,750.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $293,017.35 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Intuitive Surgical, INC. | $6,577.10 | 2019-2020 | |
| Atricure, INC. | $5,825.67 | 2019-2024 | |
| Clearflow INC. | $3,183.09 | 2019-2025 | Pleuraflow System With Flowglide |
| Abbott Laboratories | $2,994.43 | 2019-2025 | Epic, Navitor |
| Baxter Healthcare | $752.76 | 2019-2023 | Coseal |
| Davol INC. | $506.14 | 2020-2025 | Progel Applicator Spray Tips |
| Getinge USA Sales, LLC | $377.74 | 2021-2025 | Vasoview Hemopro 2, Vasoview Hemopro 2 |
| Zimmer Biomet Holdings, INC. | $370.95 | 2019-2022 | |
| Medtronic, INC. | $146.94 | 2021-2025 | Penditure, Signia |
| Kci USA, INC. | $124.83 | 2019 | |
| Angiodynamics, INC. | $87.83 | 2022-2023 | Angiovac |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $82.81 | 2024-2025 | Lifevest |
| La Jolla Pharmaceutical Company | $73.39 | 2021-2022 | |
| Medtronic Vascular, INC. | $55.50 | 2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $49.15 | 2024 | |
| Bolton Medical INC | $48.26 | 2023-2024 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Medela LLC | $45.89 | 2024 | Dominant Flex |
| Abiomed | $40.83 | 2022-2024 | Impella |
| Hemosonics LLC | $30.90 | 2022 | |
| Ethicon US, LLC | $26.03 | 2022 | |
| Becton, Dickinson and Company | $21.32 | 2025 | Progel Applicator Spray Tips |
| Livanova USA, INC. | $18.47 | 2022 | |
| Teleflex LLC | $14.15 | 2022 | |
| Kls-Martin L.P. | $13.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Logsdon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.